Search

Your search keyword '"Julie A Schneider"' showing total 771 results

Search Constraints

Start Over You searched for: Author "Julie A Schneider" Remove constraint Author: "Julie A Schneider"
771 results on '"Julie A Schneider"'

Search Results

1. A Sensitive Method for Determination 1,25-Dihydroxyvitamin D3 in Human Brain using Ultra-Pressure Liquid Chromatography Tandem Mass Spectrometry

3. PLD3 is a neuronal lysosomal phospholipase D associated with β-amyloid plaques and cognitive function in Alzheimer's disease.

4. Physical activity, brain tissue microstructure, and cognition in older adults.

5. Dementia and autopsy-verified causes of death in racially-diverse older Brazilians.

6. Deconvolving the contributions of cell-type heterogeneity on cortical gene expression.

7. Total daily physical activity, brain pathologies, and parkinsonism in older adults.

8. Cognition may link cortical IGFBP5 levels with motor function in older adults.

9. Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts.

10. Reproductive period and epigenetic modifications of the oxidative phosphorylation pathway in the human prefrontal cortex.

11. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data.

12. Ex-vivo quantitative susceptibility mapping of human brain hemispheres.

13. The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults.

14. 24-hour rhythms of DNA methylation and their relation with rhythms of RNA expression in the human dorsolateral prefrontal cortex.

15. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.

16. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers.

17. Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study.

18. Intermediate phenotypes identify divergent pathways to Alzheimer's disease.

19. Multi-omic characterization of brain changes in the vascular endothelial growth factor family during aging and Alzheimer's disease

21. FDA Oncology Center of Excellence Crowdsourcing Initiative: Outreach to the Scientific Community to Identify Research Questions for Pooled Analyses of Oncology Clinical Trial Data

22. Association of Stroke and Cerebrovascular Pathologies With Scam Susceptibility in Older Adults

23. Frequency and Underlying Pathology of Pure Vascular Cognitive Impairment

24. TDP-43 Pathology in the Setting of Intermediate and High Alzheimer’s Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups

25. Neuropathology of the Common Forms of Dementia

26. Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease

27. The status of digital pathology and associated infrastructure within Alzheimer’s Disease Centers

28. Brain copper may protect from cognitive decline and Alzheimer’s disease pathology: a community-based study

30. Differential Vulnerability of Hippocampal Subfields in Primary Age-Related Tauopathy and Chronic Traumatic Encephalopathy

31. Pelargonidin and Berry Intake Association with Alzheimer’s Disease Neuropathology: A Community-Based Study

32. Mechanical Properties of the Developing Brain are Associated with Language Input and Vocabulary Outcome

33. Neurodegenerative and Cerebrovascular Brain Pathologies Are Differentially Associated With Declining Grip Strength and Gait In Older Adults

38. Supplementary Table S2: Summary of Crowdsourcing Sumbissions Received from FDA Oncology Center of Excellence Crowdsourcing Initiative: Outreach to the Scientific Community to Identify Research Questions for Pooled Analyses of Oncology Clinical Trial Data

39. Supplementary Table S1: Pooled analyses of oncology clinical trial data 2018-2021 from FDA Oncology Center of Excellence Crowdsourcing Initiative: Outreach to the Scientific Community to Identify Research Questions for Pooled Analyses of Oncology Clinical Trial Data

40. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults

41. Supplementary Tables S1-S3 from The FDA Oncology Center of Excellence Scientific Collaborative: Charting a Course for Applied Regulatory Science Research in Oncology

42. Data from The FDA Oncology Center of Excellence Scientific Collaborative: Charting a Course for Applied Regulatory Science Research in Oncology

43. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer’s disease

44. Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease

45. New insights into the genetic etiology of Alzheimer's disease and related dementias

46. Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults

47. Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes

48. Genome-wide association study of brain arteriolosclerosis

49. Neuropathology of Vascular Brain Health: Insights From Ex Vivo Magnetic Resonance Imaging–Histopathology Studies in Cerebral Small Vessel Disease

50. Brain microRNAs are associated with variation in cognitive trajectory in advanced age

Catalog

Books, media, physical & digital resources